While many know of Amogelang (Amos) Raphenya as the Lead CARD Developer and a local, national, and international resource for genomic surveillance of antimicrobial resistance, he has also been performing separate MSc studies for the last few years and today we celebrate the completion of his MSc in Biochemistry titled, “The Human Microbiome Drug Metabolism Database”. Well done, Amos! Thank you to the Weston Family Foundation for funding his research.
